Abstract
There is a complex interplay between genetic and environmental factors that influences the expression of plasma lipoprotein levels. It is therefore not surprising that differences in lipid levels have been reported between ethnic groups. There are conflicting data on racial and ethnic variations in lipids, and also limited data on the relationship between lipoprotein levels and coronary heart disease risk in specific populations. This review summarizes available data on ethnic variations in plasma lipoproteins and the potential impact on coronary morbidity and mortality.
Similar content being viewed by others
References and Recommended Reading
Zemel PC, Sowers JR: Relation between lipids and atherosclerosis: epidemiologic evidence and clinical implications. Am J Cardiol 1990, 66:7I-12I.
Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486–2497.
D’Agostino RB, Russell MW, Huse DM, et al.: Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J 2000, 139(2 Pt 1):272–281.
Stamler J, Daviglus ML, Garside DB, et al.: Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and allcause mortality and to longevity. JAMA 2000, 284:311–318.
Neaton JD, Blackburn H, Jacobs D, et al.: Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992, 152:1490–1500.
Kromhout D: Serum cholesterol in cross-cultural perspective. The Seven Countries Study. Acta Cardiol 1999, 54:155–158.
Verschuren WM, Jacobs DR, Bloemberg BP, et al.: Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA 1995, 274:131–136.
Crook ED, Clark BL, Bradford ST, et al.: From 1960s Evans County Georgia to present-day Jackson, Mississippi: an exploration of the evolution of cardiovascular disease in African Americans. Am J Med Sci 2003, 325:307–314.
Clark LT, Ferdinand KC, Flack JM, et al.: Coronary heart disease in African Americans. Heart Dis 2001, 3:97–108.
Tyroler HA, Glueck CJ, Christensen B, et al.: Plasma high-density lipoprotein cholesterol comparisons in black and white populations The Lipid Research Clinics Program Prevalence Study. Circulation 1980, 62:99–107.
Sprafka JM, Norsted SW, Folsom AR, et al.: Life-style factors do not explain racial differences in high-density lipoprotein cholesterol: the Minnesota Heart Survey. Epidemiology 1992, 3:156–163.
Webber LS, Srinivasan SR, Wattigney WA, et al.: Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa Heart Study. Am J Epidemiol 1991, 133:884–899.
Brown SA, Hutchinson R, Morrisett J, et al.: Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1993, 13:1139–1158.
Vega GL, Clark LT, Tang A, et al.: Hepatic lipase activity is lower in African American than in white American men: Effects of 5' flanking polymorphism in the hepatic lipase gene. J Lipid Res 1998, 39:228–232. This study examined the relationship between hepatic lipase activity, plasma HDL cholesterol concentrations, and a hepatic lipase polymorphism (514T) in black and white American men. HDL choleserol concentrations were significantly higher in black men and mean postheparin plasma hepatic lipase activity was significantly lower in black than in white men. The 514T hepatic lipase allele was associated with low hepatic lipase activity in both populations, and was threefold more common among blacks than whites.
Nie L, Niu S, Vega GL, et al.: Three polymorphisms associated with low hepatic lipase activity are common in African Americans. J Lipid Res 1998, 39:1900–1903.
Metcalf PA, Sharrett AR, Folsom AR, et al.: African Americanwhite differences in lipids, lipoproteins, and apolipoproteins, by educational attainment, among middle-aged adults: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 1998, 148:750–760.
Donahue RP, Jacobs DR Jr, Sidney S, et al.: Distribution of lipoproteins and apolipoproteins in young adults The CARDIA Study. Arteriosclerosis 1989, 9:656–664.
Pablos-Mendez A, Mayeux R, Ngai C, et al.: Association of apo E polymorphism with plasma lipid levels in a multiethnic elderly population. Arterioscler Thromb Vasc Biol 1997, 17:3534–3541.
Rubins HB, Robins SJ, Collins D, et al.: Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group. Am J Cardiol 1995, 75:1196–1201.
O’Brien R: Biological importance of low-density-lipoprotein subfractions. J Cardiovasc Risk 1994, 1:207–211.
Kral BG, Becker LC, Yook RM, et al.: Racial differences in lowdensity lipoprotein particle size in families at high risk for premature coronary heart disease. Ethn Dis 2001, 11:325–337.
Uterman G: The mysteries of lipoprotein(a). Science 1989, 246:904–910.
Gunther MF, Catherin AR, Angelo MS: Heterogeneity of human lipoprotein(a). J Biol Chem 1984, 259:11470–11478.
Para HG, Luyey I, Buramoue C, et al.: Black-white differences in serum lipoprotein(a) levels. Clin Chim Acta 1987, 167:27–31.
Scanu AM: Lipoprotein(a): a genetic risk factor for premature coronary heart disease. JAMA, 1992, 267:3326–3329.
Macovina SM, Koshchinsky ML: Lipoprotein(a) as a risk factor for coronary artery disease. Am J Cardiol 1998, 82:57U-66U.
Rim L, Ali B, Slim BA, Bechir Z: Lipoprotein(a): a new risk factor for coronary artery disease. Tunis Med 2000, 78:648–652.
Ridker PM, Hennekens CH, Stampfer MJ: A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA 1993, 270:2195–2199.
Wild SH, Fortmann SP, Marcovina SM: A prospective casecontrol study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants. Arterioscler Thromb Vasc Biol 1997, 17:239–245.
Sandholzer C, Saha N, Kark JD, et al.: Apo(a) isoforms predict risk for coronary heart disease: a study in six populations. Arterioscler Thromb 1992, 12:1214–1226.
Moliterno DJ, Jokinen EV, Miserez AR, et al.: No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans. Arterioscler Thromb Vasc Biol 1995, 15:850–855.
Sorrentino MJ, Vielhauer C, Eisenbart JD, et al.: Plasma lipoprotein(a) protein concentration and coronary artery disease in black patients compared with white patients. Am J Med 1992, 93:658–662.
Marcovina SM, Albers JJ, Wijsman E, et al.: Differences in Lp(a) concentrations and apo(a) polymorphs between black and white Americans. J Lipid Res 1996, 37:2569–2585.
Paultre F, Pearson TA, Weil HF, et al.: High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men. Arterioscler Thromb Vasc Biol 2000, 20:2619–2624. The authors investigated the hypothesis that apo(a) isoform size determines the association between Lp(a) and CHD. They related Lp(a) levels, apo(a) isoforms, and the levels of Lp(a) associated with different apo(a) isoforms to the presence of CHD in 576 white and black men and women. Elevated Lp(a) levels (≥ 30 mg/dL) were found in 26% of whites and 68% of blacks, and of those, 80% of whites but only 26% of blacks had a small apo(a) isoform. Elevated Lp(a) levels with small apo(a) isoforms were significantly associated with CAD (P < 0.01) in black and white men but not in women.
Lillie-Blanton M, Martinez RM, Taylor AK, Robinson BG: Latina and African American women: continuing disparities in health. Int J Health Serv 1993, 23:555–584.
O’Hare WP: Hispanic Americans in the 1980s: mainstream or minority? Popul Today 1989, 17:6–8.
Bureau of the Census: Statistical Tables for the Hispanic Origin Population from the March 1994 Current Population Survey. Washington, DC: Bureau of the Census; 1995.
Aguilar-Salinas CA, Olaiz G, Valles V, et al.: High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey. J Lipid Res 2001, 42:1298–1307. Information was obtained on 15,607 subjects, aged 20 to 69 years. Mean total cholesterol concentration in this cohort was185 mg/dL, mean TG level was 212 mg/dL, mean HDL level was 40 mg/dL, and mean LDL concentration was 118 mg/dL.
Hanis CL, Hewett-Emmett D, Douglas TC, Schull WJ: Lipoprotein and apolipoprotein levels among Mexican-Americans in Starr County, Texas. Arterioscler Thromb 1991, 11:123–129.
Reaven P, Nader PR, Berry C, Hoy T: Cardiovascular disease insulin risk in Mexican-American and Anglo-American children and mothers. Pediatrics 1998,101:E12.
Bermudez OI, Velez-Carrasco W, Schaefer EJ, Tucker KL: Dietary and plasma lipid, lipoprotein, and apolipoprotein profiles among elderly Hispanics and non-Hispanics and their association with diabetes. Am J Clin Nutr 2002, 76:1214–1221.
Haffner SM, D’Agostino R Jr., Goff D, et al.: LDL size in African Americans, Hispanics, and non-Hispanic whites: the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol 1999, 19: 2234–2240. The authors examined LDL size in 1571 subjects from the Insulin Resistance Atherosclerosis Study. LDL size was significantly different by ethnic group (blacks 262.1 ± 0.6, Hispanics 257.6 ± 0.6, and non-Hispanic whites 259.2 ± 0.4; P < 0.001).
Chiu L, Hamman RF, Kamboh MI: Apolipoprotein A polymorphisms and plasma lipoprotein(a) concentrations in non-Hispanic whites and Hispanics. Hum Biol 2000, 72:821–835.
Harwell TS, Moore K, McDowall JM, et al.: Cardiovascular risk factors in Montana American Indians with and without diabetes. Am J Prev Med 2003, 24:265–269.
Howard BV, Lee ET, Cowan LD, et al.: The rising tide of cardiovascular disease in American Indians: the Strong Heart Study. Circulation 1999, 99:2389–2395.
Yurgalevitch SM, Kriska AM, Welty TK, et al.: Physical activity and lipids and lipoproteins in American Indians ages 45–74. Med Sci Sports Exerc 1998, 30:543–549.
Freedman DS, Serdula MK, Percy CA, et al.: Obesity, levels of lipids and glucose, and smoking among Navajo adolescents. J Nutr. 1997, 127(10 Suppl):2120S-2127S. A total of 160 12- to 19-year-old Navajo subjects were examined. Levels of total cholesterol and blood pressure were similar to those in the general US population, but Navajo adolescents had a 5- to 10-mg/ dL lower median level of HDL cholesterol, and a 30 mg/dL higher median TG level.
Wang W, Hu D, Lee ET, et al.: Lipoprotein(a) in American Indians is low and not independently associated with cardiovascular disease. The Strong Heart Study. Ann Epidemiol 2002, 12:107–114.
Enas EA, Mehta J: Malignant coronary artery disease in young Asian Indians: thoughts on pathogenesis, prevention and therapy. Clin Cardiol 1995, 18:131–135. This article summarizes information on CHD in Asian Indians. The author emphasizes that although the incidence of classic risk factors is low in this population, high TG, low HDL levels, high Lp(a) levels, and hyperinsulinemia all show a substantial prevalence in this population.
Miller GJ, Kotecha S, Wilkinson WH, et al.: Dietary and other characteristics relevant for coronary heart disease in men of Indian, West Indian and European descent in London. Atherosclerosis 1988, 70:63–72.
Hoogeveen RC, Gambhir JK, Gambhir DS, et al.: Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts. J Lipid Res 2001, 42:631–638.
Cruickshank JK, Cooper J, Burnett M, et al.: Ethnic differences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure. Lancet 1991, 338:842–847.
McKeigue PM, Shah B, Marmot MG: Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991, 337:382–386.
Raji A, Seely EW, Arky RA, Simonson DC: Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 2001, 86:5366–5371.
Kulkarni KR, Markovitz JH, Nanda NC, Segrest JP: Increased prevalence of smaller and denser LDL particles in Asian Indians. Arterioscler Thromb Vasc Biol 1999, 19:2749–2755.
Isser HS, Puri VK, Narain VS, et al.: Lipoprotein (a) and lipid levels in young patients with myocardial infarction and their first-degree relatives. Indian Heart J 2001, 53:463–466.
Velmurugan K, Deepa R, Ravikumar R, et al.: Relationship of lipoprotein(a) with intimal medial thickness of the carotid artery in type 2 diabetic patients in south India. Diabetic Medicine 2003, 20:455–461.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Watson, K.E. Plasma lipoprotein concentrations in ethnic populations. Curr Cardiol Rep 5, 483–487 (2003). https://doi.org/10.1007/s11886-003-0111-3
Issue Date:
DOI: https://doi.org/10.1007/s11886-003-0111-3